Workout
Healthy Eating Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process Contact Us
Health Tracker
AI Tools
✔Fact Checked

Juventus will present a new offer for Barcelona defender Ronald Araujo

Article Updated On:
Photo of author
FitToFar
Published On:

Barcelona arrived in the Catalan capital only early on Monday morning, still stunned by the dream victory over Real Madrid in the Spanish Super Cup final. However, sports director Deco will return to activity immediately upon his return.

This is because Juventus will present an improved offer for Ronald Araujo on Monday afternoon, according to Relevo. The Bianconeri are discussing an offer that could reach €50 million, a figure believed to be close to Barcelona’s valuation of the Uruguayan defender, although they are expected to ask for more. An injury to Íñigo Martínez that could keep him out for the next five weeks has been cited as a potential obstacle to the deal, but Barcelona are more likely to enter the transfer market rather than halt the sale of Araujo to cover the defender. Basque.

Previous reports from late last week claimed that Barcelona had already rejected an offer from Juventus worth around €35 ​​million. This week a meeting is scheduled between Deco and Araujo’s agents, where Barcelona will address their intentions. If he asks to leave, Barcelona are expected to negotiate his sale.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

Read This Next


dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.

 

SHARE YOUR FEEDBACK

SHARE YOUR FEEDBACK